ZoyeMed 3.0, an edge-native autonomous clinical terminal developed by Zoya Technologies, designed to support primary and acute care using on-device intelligence and multimodal sensing. The interface shown represents a neutral, multilingual system layer and does not display clinical data. (Photo: AETOSWire)
FORGET DOCTORS. A SHOCKING new era of MEDICINE has been declared, as Zoya Technologies unveils a machine designed to REPLACE human clinicians in vulnerable communities worldwide. The so-called “ZoyeMed 3.0” is NOT a tool—it’s an AUTONOMOUS clinical terminal, a HAL for healthcare promising to deliver “primary and acute care” with chillingly vague “humans in the loop.” This is the CLOUD-FREE, judgement-free future of medicine, and it’s being rolled out FIRST in Mexico and Colombia, with the Global South treated as a corporate proving ground for AI-led medical triage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209475744/en/
This isn’t innovation; it’s a DANGEROUS experiment. The company boasts a “closed-loop, edge-first architecture,” bragging it functions in areas with “limited bandwidth” and “staffing constraints.” Translation: Where human care is stretched thinnest, where oversight is weakest, a black-box machine will now make life-altering diagnostic calls. Zoya’s CEO chillingly states the goal is to move “clinical intelligence closer to the patient,” a clinical euphemism for REMOVING the empathetic human physician from the equation entirely.
They’ve already shipped 44 units and have contracts for HUNDREDS more, targeting Latin America, the Middle East, and South Asia. This is a coordinated corporate LAND GRAB on the very fabric of healthcare, reducing the sacred patient-doctor relationship to a transaction with a “multimodal sensing” terminal. They call it “physical healthcare infrastructure.” Critics call it the final, profits-first step toward MEDICAL DESKILLING on a global scale.
“ZoyeMed 3.0 moves clinical intelligence closer to the patient,” said Dr. Syed Sabahat Azim, Chief Executive Officer of Zoya Technologies. “By operating at the edge, the system is designed to function reliably even when connectivity is limited, while building a longitudinal view of patient health over time.”
The dystopian rollout is already underway. A single, stark question remains: When your diagnosis comes from a faceless terminal operating without oversight, who do you sue when it’s lethally wrong?
Author: Kayitsi.com
